In this phase III , randomized , double-blind , multicenter , @-week study , the primary study end point was HbA@c change from baseline at week @ in patients with renal impairment , as assessed with estimated glomerular filtration rate and categorized as mild , moderate , or severe ( @ to @ , @ to @ , and @ to @ mL/min/@ @ m ( @ ) , respectively ) .